Division of Immunology/Allergy Section, Department of Internal Medicine, University of Cincinnati, Ohio, USA.
Allergy Asthma Proc. 2011 Nov-Dec;32(6):408-12. doi: 10.2500/aap.2011.32.3469.
Hereditary Angioedema (HAE) is a multisystem, autosomal dominant disease that affects ∼1:10,000 to 1:50,000 individuals in the United States. The disease has several clinical characteristics that distinguish it from other forms of angioedema. Recurrent swelling attacks involve the abdomen, face, extremities, genitalia, oropharynx, or larynx without urticaria. The swelling attacks are typically unilateral, nonpitting, nonpruritic, and, although uncomfortable, are often painless. Other forms of isolated angioedema such as acquired angioedema and angiotensin-converting enzyme-induced angioedema have similar characteristics of HAE. Therefore, evaluation of patients with recurrent angioedema should be directed at excluding these different forms of angioedema before a diagnosis of idiopathic angioedema is made. The objective of this article is to provide an overview of the differential diagnosis of angioedema that reflects the angioedema guidelines that are currently in development.
遗传性血管性水肿(HAE)是一种多系统常染色体显性遗传病,在美国每 10000 至 50000 人中就有 1 人患病。该病具有几种与其他类型血管性水肿不同的临床特征。反复发作的肿胀累及腹部、面部、四肢、生殖器、口咽或喉部,不伴荨麻疹。肿胀发作通常为单侧、非凹陷性、非瘙痒性,虽然不适,但通常无疼痛。获得性血管性水肿和血管紧张素转换酶诱导的血管性水肿等其他类型孤立性血管性水肿具有与 HAE 相似的特征。因此,在做出特发性血管性水肿的诊断之前,应针对反复发作性血管性水肿患者的评估,排除这些不同类型的血管性水肿。本文的目的是提供血管性水肿鉴别诊断的概述,该概述反映了当前正在制定的血管性水肿指南。